Refine
Year of publication
Document Type
- Article (87)
- Contribution to a Periodical (4)
- Preprint (2)
- Part of a Book (1)
Has Fulltext
- yes (94)
Is part of the Bibliography
- no (94)
Keywords
- NMR spectroscopy (14)
- SARS-CoV-2 (11)
- RNA (10)
- COVID19-NMR (5)
- G-quadruplexes (4)
- NMR (4)
- Solution NMR spectroscopy (4)
- Solution NMR-spectroscopy (4)
- rna (4)
- structural biology (4)
- 5′-UTR (3)
- Covid19-NMR (3)
- Mycobacterium tuberculosis (3)
- Non-structural protein (3)
- Protein drugability (2)
- RNA structures (2)
- aptamers (2)
- base pairing (2)
- biophysics (2)
- heteronuclear detection (2)
- kinetics (2)
- nuclear magnetic resonance spectroscopy (2)
- proteins (2)
- proteomics (2)
- reactive oxygen species (2)
- real-time NMR spectroscopy (2)
- small protein (2)
- small proteins (2)
- structure elucidation (2)
- 19F (1)
- 19F MR spectroscopy (1)
- 1H MR spectroscopy (1)
- 2'-deoxyguanosine riboswitch (1)
- 2-hydroxyglutarate (1)
- 2D NMR spectroscopy (1)
- 5'-UTR (1)
- 5_SL4 (1)
- ATG3 (1)
- B. subtilis (1)
- Bacterial Protein Kinases (1)
- Bacterial Protein Phosphatases (1)
- Biochemie (1)
- Biotin (1)
- Bradyrhizobium (1)
- C-mannosylation (1)
- CEST (1)
- COVID-19 (1)
- Covid19-nmr (1)
- DNA (1)
- DNA-PAINT (1)
- DNA-ligand complexes (1)
- Dimerization domain (1)
- Direct carbon (1)
- Drug Resistance (1)
- Drug discovery (1)
- Dynamische Kernpolarisation (1)
- E. coli (1)
- Echtzeit-NMR-Spektroskopie (1)
- Empfindlichkeitsverstärkung (1)
- Eph receptors (1)
- Ephrin ligand (1)
- Esters (1)
- Eukaryota (1)
- FBDD (1)
- FBS (1)
- FGFR (1)
- Fragment (1)
- G-protein-coupled receptors (1)
- G-quadruplex binders (1)
- Haloferax volcanii (1)
- HeLa cells (1)
- High-throughput screening (1)
- Hohes Magnetfeld (1)
- IDH mutation (1)
- IDH1 inhibitor (1)
- Internal ribosome entry site (1)
- Ligands (1)
- Low Molecular Weight PTP (1)
- Luciferase (1)
- Macrodomain (1)
- Methanosarcina mazei (1)
- Molecular modelling (1)
- MptpA (1)
- NMR Spectroscopy (1)
- NMR solution structure (1)
- NMR-Spektroskopie (1)
- NOESY (1)
- Nuclear magnetic resonance (1)
- Nucleic acid-binding domain (1)
- Nucleocapsid (1)
- Personalisierte Medizin (1)
- Phosphorylation (1)
- Primary metabolites (1)
- Protein druggability (1)
- Protein translation (1)
- PtkA (1)
- Quality control (1)
- RNA genome (1)
- RNA sequencing (RNA-Seq) (1)
- RNA stability (1)
- RNA synthesis (1)
- RNA therapy (1)
- RNASolution-state NMR (1)
- SHAPE analysis (1)
- SL1 (1)
- SL5a (1)
- SL5b (1)
- SL5b + c (1)
- SL5c (1)
- SSR128129E (1)
- Secondary metabolites (1)
- Shine-Dalgarno (1)
- Sinorhizobium fredii (1)
- Solubility (1)
- Solution-state NMR (1)
- Soybean (1)
- Stoffwechsel (1)
- Structural protein (1)
- TERRA RNA (1)
- Target validation (1)
- Translation initiation (1)
- UV/Vis spectroscopy (1)
- X-ray diffraction (1)
- Zellstudien (1)
- a-proteobacteria (1)
- accessory proteins (1)
- acute myeloid leukemia (1)
- adenine (1)
- alkylation (1)
- allostery (1)
- amino acids (1)
- analysis (1)
- analytical chemistry (1)
- antibiotics (1)
- autophagy (1)
- autophagy inhibition (1)
- barstar (1)
- biochemistry (1)
- biological chemistry (1)
- biological models (1)
- biophysical investigation (1)
- c-Myc (1)
- carbazole ligands (1)
- carbon direct detection (1)
- cell death (1)
- cell studies (1)
- cell-free protein synthesis (1)
- chemoenzymatic synthesis (1)
- chronic myeloid leukemia (1)
- circular dichroism (1)
- click chemistry (1)
- colorectal cancer (1)
- computational chemistry (1)
- conformation analysis (1)
- cysteine reactivity (1)
- cysteine-redox regulation (1)
- cytochromes (1)
- detection (1)
- diagnostic radiologic examination (1)
- drug design (1)
- entropy (1)
- eph receptor tyrosin kinase family (1)
- ephrins (1)
- fluorescence (1)
- fluorine (1)
- folding (1)
- folding landscapes (1)
- fragment screening (1)
- fragment-based screening (1)
- genetic code expansion (1)
- glioma (1)
- glutamine synthetase regulation (1)
- glutathione (1)
- glutathionylation (1)
- glycoproteins (1)
- guanidine riboswitch (1)
- hydroxynaphthoquinone (1)
- inhibitor (1)
- inhibitor design (1)
- intrinsically disordered protein (1)
- intrinsically disordered region (1)
- ions (1)
- isotope labeling (1)
- large functional RNAs (1)
- ligand design (1)
- ligands (1)
- ligases (1)
- light control (1)
- meta-stable structures (1)
- metabolic reprogramming (1)
- metabolic rewiring (1)
- metabolism (1)
- metals (1)
- molecular conformation (1)
- murine model (1)
- nitrogen direct detection (1)
- nitrogen regulation (1)
- nitroindoles (1)
- nitrosylation (1)
- non-canonical amino acid (1)
- non-natural nucleotide (1)
- nonstructural proteins (1)
- nucleobases (1)
- oligonucleotides (1)
- oncogene promoters (1)
- oxidases (1)
- oxidative folding (1)
- personalized medicine (1)
- photochemistry (1)
- plant symbioses (1)
- plasmid copy number (1)
- precision (1)
- proline isomerization (1)
- protein denaturation (1)
- protein folding (1)
- protein oxidation (1)
- protein phosphorylation (1)
- protein tyrosine kinase (1)
- protein tyrosine phosphatase (1)
- protons (1)
- quorum sensing (QS) (1)
- reductases (1)
- regioisomers (1)
- retinal (1)
- rhodopsin (1)
- ribosomal binding site (1)
- ribosomal exit tunnel (1)
- ribosome (1)
- riboswitches (1)
- ribozymes (1)
- roentgen rays (1)
- sORF (1)
- salmonella (1)
- selective isotopic labeling (1)
- site-specific labeling (1)
- small ORFs (1)
- small gene (1)
- small molecule inhibitor (1)
- solid-phase synthesis (1)
- spectrum (1)
- spectrum analysis (1)
- structural proteins (1)
- structure-activity relationships (1)
- structure–activity relationships (1)
- targeted therapy (1)
- temperature (1)
- temperature jump (1)
- thermometers (1)
- thiostrepton (1)
- transcription (1)
- transient complex (1)
- translation initiation region (1)
- tumor angiogenesis (1)
- tumor hypoxia (1)
- tumor perfusion (1)
- tyrosine kinase inhibitors (1)
- tyrosine kinase inhibitors. (1)
- tyrosine kinase signaling (1)
- zinc finger (1)
- µ-protein (1)
Institute
- Biochemie und Chemie (47)
- Zentrum für Biomolekulare Magnetische Resonanz (BMRZ) (44)
- Biochemie, Chemie und Pharmazie (35)
- Exzellenzcluster Makromolekulare Komplexe (23)
- Sonderforschungsbereiche / Forschungskollegs (23)
- Biowissenschaften (19)
- Medizin (7)
- Präsidium (4)
- Georg-Speyer-Haus (3)
- Frankfurt Institute for Advanced Studies (FIAS) (1)
We propose a generalized modeling framework for the kinetic mechanisms of transcriptional riboswitches. The formalism accommodates time-dependent transcription rates and changes of metabolite concentration and permits incorporation of variations in transcription rate depending on transcript length. We derive explicit analytical expressions for the fraction of transcripts that determine repression or activation of gene expression, pause site location and its slowing down of transcription for the case of the (2’dG)-sensing riboswitch from Mesoplasma florum. Our modeling challenges the current view on the exclusive importance of metabolite binding to transcripts containing only the aptamer domain. Numerical simulations of transcription proceeding in a continuous manner under time-dependent changes of metabolite concentration further suggest that rapid modulations in concentration result in a reduced dynamic range for riboswitch function regardless of transcription rate, while a combination of slow modulations and small transcription rates ensures a wide range of finely tuneable regulatory outcomes.
Mitte März des letzten Jahres erreichte die Corona-Pandemie dann auch die Goethe-Universität: Der Lehrbetrieb in den folgenden Semestern wurde und wird hauptsächlich im digitalen Modus durchgeführt, viele Mitarbeiter*innen arbeiten seitdem im Homeoffice, Hygiene- und Abstandsregeln gelten in Räumen und auf Plätzen. In kürzester Zeit mussten Arbeitsabläufe neu organisiert und viele Services auf digitale Prozesse umgestellt werden. Aber das Wichtigste: Die Infektionszahlen konnten gering gehalten werden. Der UniReport hat einige Hochschulangehörige aus Wissenschaft, Verwaltung und Studierendenschaft nach ihren Erfahrungen und Erkenntnissen in diesem außergewöhnlichen Jahr befragt.
The c-MYC proto-oncogene is a regulator of fundamental cellular processes such as cell cycle progression and apoptosis. The development of novel c-MYC inhibitors that can act by targeting the c-MYC DNA G-quadruplex at the level of transcription would provide potential insight into structure-based design of small molecules and lead to a promising arena for cancer therapy. Herein we report our finding that two simple bis-triazolylcarbazole derivatives can inhibit c-MYC transcription, possibly by stabilizing the c-MYC G-quadruplex. These compounds are prepared using a facile and modular approach based on Cu(I) catalysed azide and alkyne cycloaddition. A carbazole ligand with carboxamide side chains is found to be microenvironment-sensitive and highly selective for "turn-on" detection of c-MYC quadruplex over duplex DNA. This fluorescent probe is applicable to visualize the cellular nucleus in living cells. Interestingly, the ligand binds to c-MYC in an asymmetric fashion and selects the minor-populated conformer via conformational selection.
We investigated the folding kinetics of G-quadruplex (G4) structures by comparing the K+-induced folding of an RNA G4 derived from the human telomeric repeat-containing RNA (TERRA25) with a sequence homologous DNA G4 (wtTel25) using CD spectroscopy and real-time NMR spectroscopy. While DNA G4 folding is biphasic, reveals kinetic partitioning and involves kinetically favoured off-pathway intermediates, RNA G4 folding is faster and monophasic. The differences in kinetics are correlated to the differences in the folded conformations of RNA vs. DNA G4s, in particular with regard to the conformation around the glycosidic torsion angle χ that uniformly adopts anti conformations for RNA G4s and both, syn and anti conformation for DNA G4s. Modified DNA G4s with 19F bound to C2′ in arabino configuration adopt exclusively anti conformations for χ. These fluoro-modified DNA (antiTel25) reveal faster folding kinetics and monomorphic conformations similar to RNA G4s, suggesting the correlation between folding kinetics and pathways with differences in χ angle preferences in DNA and RNA, respectively.
Genetic code expansion facilitates position‐selective labeling of rna for biophysical studies
(2019)
Nature relies on reading and synthesizing the genetic code with high fidelity. Nucleic acid building blocks that are orthogonal to the canonical A‐T and G‐C base‐pairs are therefore uniquely suitable to facilitate position‐specific labeling of nucleic acids. Here, we employ the orthogonal kappa‐xanthosine‐base‐pair for in vitro transcription of labeled RNA. We devised an improved synthetic route to obtain the phosphoramidite of the deoxy‐version of the kappa nucleoside in solid phase synthesis. From this DNA template, we demonstrate the reliable incorporation of xanthosine during in vitro transcription. Using NMR spectroscopy, we show that xanthosine introduces only minor structural changes in an RNA helix. We furthermore synthesized a clickable 7‐deaza‐xanthosine, which allows to site‐specifically modify transcribed RNA molecules with fluorophores or other labels.
Photolabile protecting groups are widely used to trigger oligonucleotide activity. The ON/OFF‐amplitude is a critical parameter. An experimental setup has been developed to identify protecting group derivatives with superior caging properties. Bulky rests are attached to the cage moiety via Cu‐catalyzed azide–alkyne cycloaddition post‐synthetically on DNA. Interestingly, the decrease in melting temperature upon introducing o‐nitrobenzyl‐caged (NPBY‐) and diethylaminocoumarin‐cages (DEACM‐) in DNA duplexes reaches a limiting value. NMR spectroscopy was used to characterize individual base‐pair stabilities and determine experimental structures of a selected number of photocaged DNA molecules. The experimental structures agree well with structures predicted by MD simulations. Combined, the structural data indicate that once a sterically demanding group is added to generate a tri‐substituted carbon, the sterically less demanding cage moiety points towards the neighboring nucleoside and the bulkier substituents remain in the major groove.
Herein, we present a multi-cycle chemoenzymatic synthesis of modified RNA with simplified solid-phase handling to overcome size limitations of RNA synthesis. It combines the advantages of classical chemical solid-phase synthesis and enzymatic synthesis using magnetic streptavidin beads and biotinylated RNA. Successful introduction of light-controllable RNA nucleotides into the tRNAMet sequence was confirmed by gel electrophoresis and mass spectrometry. The methods tolerate modifications in the RNA phosphodiester backbone and allow introductions of photocaged and photoswitchable nucleotides as well as photocleavable strand breaks and fluorophores.
We report here the nuclear magnetic resonance 19F screening of 14 RNA targets with different secondary and tertiary structure to systematically assess the druggability of RNAs. Our RNA targets include representative bacterial riboswitches that naturally bind with nanomolar affinity and high specificity to cellular metabolites of low molecular weight. Based on counter-screens against five DNAs and five proteins, we can show that RNA can be specifically targeted. To demonstrate the quality of the initial fragment library that has been designed for easy follow-up chemistry, we further show how to increase binding affinity from an initial fragment hit by chemistry that links the identified fragment to the intercalator acridine. Thus, we achieve low-micromolar binding affinity without losing binding specificity between two different terminator structures.
Tyrosine kinase inhibitors (TKIs) are currently the standard chemotherapeutic agents for the treatment of chronic myeloid leukemia (CML). However, due to TKI resistance acquisition in CML patients, identification of new vulnerabilities is urgently required for a sustained response to therapy. In this study, we have investigated metabolic reprogramming induced by TKIs independent of BCR-ABL1 alterations. Proteomics and metabolomics profiling of imatinib-resistant CML cells (ImaR) was performed. KU812 ImaR cells enhanced pentose phosphate pathway, glycogen synthesis, serine-glycine-one-carbon metabolism, proline synthesis and mitochondrial respiration compared with their respective syngeneic parental counterparts. Moreover, the fact that only 36% of the main carbon sources were utilized for mitochondrial respiration pointed to glycerol-phosphate shuttle as mainly contributors to mitochondrial respiration. In conclusion, CML cells that acquire TKIs resistance present a severe metabolic reprogramming associated with an increase in metabolic plasticity needed to overcome TKI-induced cell death. Moreover, this study unveils that KU812 Parental and ImaR cells viability can be targeted with metabolic inhibitors paving the way to propose novel and promising therapeutic opportunities to overcome TKI resistance in CML.
Both the genomes of the epsilonproteobacteria Wolinella succinogenes and Campylobacter jejuni contain operons (sdhABE) that encode for so far uncharacterized enzyme complexes annotated as ‘non-classical’ succinate:quinone reductases (SQRs). However, the role of such an enzyme ostensibly involved in aerobic respiration in an anaerobic organism such as W. succinogenes has hitherto been unknown. We have established the first genetic system for the manipulation and production of a member of the non-classical succinate:quinone oxidoreductase family. Biochemical characterization of the W. succinogenes enzyme reveals that the putative SQR is in fact a novel methylmenaquinol:fumarate reductase (MFR) with no detectable succinate oxidation activity, clearly indicative of its involvement in anaerobic metabolism. We demonstrate that the hydrophilic subunits of the MFR complex are, in contrast to all other previously characterized members of the superfamily, exported into the periplasm via the twin-arginine translocation (tat)-pathway. Furthermore we show that a single amino acid exchange (Ala86→His) in the flavoprotein of that enzyme complex is the only additional requirement for the covalent binding of the otherwise non-covalently bound FAD. Our results provide an explanation for the previously published puzzling observation that the C. jejuni sdhABE operon is upregulated in an oxygen-limited environment as compared with microaerophilic laboratory conditions.
The cell division cycle protein 37 (Cdc37) and the 90-kDa heat shock protein (Hsp90) are molecular chaperones, which are crucial elements in the protein signaling pathway. The largest class of client proteins for Cdc37 and Hsp90 are protein kinases. The catalytic domains of these kinases are stabilized by Cdc37, and their proper folding and functioning is dependent on Hsp90. Here, we present the x-ray crystal structure of the 16-kDa middle domain of human Cdc37 at 1.88 angstroms resolution and the structure of this domain in complex with the 23-kDa N-terminal domain of human Hsp90 based on heteronuclear solution state NMR data and docking. Our results demonstrate that the middle domain of Cdc37 exists as a monomer. NMR and mutagenesis experiments reveal Leu-205 in Cdc37 as a key residue enabling complex formation. These findings can be very useful in the development of small molecule inhibitors against cancer.
In bacteria, the regulation of gene expression by cis-acting transcriptional riboswitches located in the 5'-untranslated regions of messenger RNA requires the temporal synchronization of RNA synthesis and ligand binding-dependent conformational refolding. Ligand binding to the aptamer domain of the riboswitch induces premature termination of the mRNA synthesis of ligand-associated genes due to the coupled formation of 3'-structural elements acting as terminators. To date, there has been no high resolution structural description of the concerted process of synthesis and ligand-induced restructuring of the regulatory RNA element. Here, we show that for the guanine-sensing xpt-pbuX riboswitch from Bacillus subtilis, the conformation of the full-length transcripts is static: it exclusively populates the functional off-state but cannot switch to the on-state, regardless of the presence or absence of ligand. We show that only the combined matching of transcription rates and ligand binding enables transcription intermediates to undergo ligand-dependent conformational refolding.
Translational riboswitches are cis-acting RNA regulators that modulate the expression of genes during translation initiation. Their mechanism is considered as an RNA-only gene-regulatory system inducing a ligand-dependent shift of the population of functional ON- and OFF-states. The interaction of riboswitches with the translation machinery remained unexplored. For the adenine-sensing riboswitch from Vibrio vulnificus we show that ligand binding alone is not sufficient for switching to a translational ON-state but the interaction of the riboswitch with the 30S ribosome is indispensable. Only the synergy of binding of adenine and of 30S ribosome, in particular protein rS1, induces complete opening of the translation initiation region. Our investigation thus unravels the intricate dynamic network involving RNA regulator, ligand inducer and ribosome protein modulator during translation initiation.
Riboswitches are highly structured elements in the 50-untranslated regions (50-UTRs) of messenger RNA that control gene expression by specifically binding to small metabolite molecules. They consist of an aptamer domain responsible for ligand binding and an expression platform. Ligand binding in the aptamer domain leads to conformational changes in the expression platform that result in transcription termination or abolish ribosome binding. The guanine riboswitch binds with high-specificity to guanine and hypoxanthine and is among the smallest riboswitches described so far. The X-ray-structure of its aptamer domain in complex with guanine/ hypoxanthine reveals an intricate RNA-fold consisting of a three-helix junction stabilized by longrange base pairing interactions. We analyzed the conformational transitions of the aptamer domain induced by binding of hypoxanthine using highresolution NMR-spectroscopy in solution. We found that the long-range base pairing interactions are already present in the free RNA and preorganize its global fold. The ligand binding core region is lacking hydrogen bonding interactions and therefore likely to be unstructured in the absence of ligand. Mg2+-ions are not essential for ligand binding and do not change the structure of the RNA-ligand complex but stabilize the structure at elevated temperatures. We identified a mutant RNA where the long-range base pairing interactions are disrupted in the free form of the RNA but form upon ligand binding in an Mg2+-dependent fashion. The tertiary interaction motif is stable outside the riboswitch context.
Ribosomal proteins are assumed to stabilize specific RNA structures and promote compact folding of the large rRNA. The conformational dynamics of the protein between the bound and unbound state play an important role in the binding process. We have studied those dynamical changes in detail for the highly conserved complex between the ribosomal protein L11 and the GTPase region of 23S rRNA. The RNA domain is compactly folded into a well defined tertiary structure, which is further stabilized by the association with the C-terminal domain of the L11 protein (L11ctd). In addition, the N-terminal domain of L11 (L11ntd) is implicated in the binding of the natural thiazole antibiotic thiostrepton, which disrupts the elongation factor function. We have studied the conformation of the ribosomal protein and its dynamics by NMR in the unbound state, the RNA bound state and in the ternary complex with the RNA and thiostrepton. Our data reveal a rearrangement of the L11ntd, placing it closer to the RNA after binding of thiostrepton, which may prevent binding of elongation factors. We propose a model for the ternary L11–RNA–thiostrepton complex that is additionally based on interaction data and conformational information of the L11 protein. The model is consistent with earlier findings and provides an explanation for the role of L11ntd in elongation factor binding.
Oral presentations Background: We selected peptide ligands for the HIV-1 packaging signal PSI by screening phage displayed peptide libraries. Peptide ligands were optimized by screening spot synthesis peptide membranes. The aim of this study is the functional characterization of these peptide ligands with respect to inhibition of HIV-1 replication. Methods: Phage displayed peptide libraries were screened with PSI-RNA structures. The Trp-rich peptide motifs were optimized for specific binding on spot synthesis peptide membranes. The best binding peptide was expressed intracellularly in fusion with RFP or linked to a protein transduction domain (PTD) for intracellular delivery. The effects on virion production were analyzed using pseudotyped lentiviral particles. Results: After positive and negative selection rounds, phages binding specifically to PSI-RNA were identified by ELISA. Peptide inserts contained conserved motifs of aromatic amino acids known to be implicated in binding of PSI-RNA by the natural Gag ligand. The filter assay identified HKWPWW as the best binding ligand for PSI-RNA, which is delivered into several cell lines by addition of a PTD. Compared to a control peptide, the HKWPWW peptide inhibited HIV-1 replication as deduced from reduced titers of culture supernatants. As HKWPWW also binds to the TAR-RNA like the natural nucleocapsid PSI-RNA ligand, the effect on Tat-TAR inhibition will also be analyzed. Currently T-cell lines are established which stably express HKWPWW as well as a control peptide, which will be infected with HIV-1 to monitor the ability of HKWPWW to inhibit wild type HIV-1 replication. Conclusion: The selection of a peptide ligand for PSI-RNA able to inhibit HIV-1 replication proves the suitability of the phage display technology for the selection of peptides binding to RNA-structures. This enables the indentification of peptides serving as leads to interfere with additional targets in the HIV-1 replication cycle.
Simple Summary: Targeted therapies are of growing interest to physicians in cancer treatment. These drugs target specific genes and proteins involved in the growth and survival of cancer cells. Brain tumor therapy is complicated by the fact that not all drugs can penetrate the blood brain barrier and reach their target. We explored the non-invasive method, Magnetic Resonance Spectroscopy, for monitoring drug penetration and its effects in live animals bearing brain tumors. We were able to show the presence of the investigated drug in mouse brains and its on-target activity.
Abstract: Background: BAY1436032 is a fluorine-containing inhibitor of the R132X-mutant isocitrate dehydrogenase (mIDH1). It inhibits the mIDH1-mediated production of 2-hydroxyglutarate (2-HG) in glioma cells. We investigated brain penetration of BAY1436032 and its effects using 1H/19F-Magnetic Resonance Spectroscopy (MRS). Methods: 19F-Nuclear Magnetic Resonance (NMR) Spectroscopy was conducted on serum samples from patients treated with BAY1436032 (NCT02746081 trial) in order to analyze 19F spectroscopic signal patterns and concentration-time dynamics of protein-bound inhibitor to facilitate their identification in vivo MRS experiments. Hereafter, 30 mice were implanted with three glioma cell lines (LNT-229, LNT-229 IDH1-R132H, GL261). Mice bearing the IDH-mutated glioma cells received 5 days of treatment with BAY1436032 between baseline and follow-up 1H/19F-MRS scan. All other animals underwent a single scan after BAY1436032 administration. Mouse brains were analyzed by liquid chromatography-mass spectrometry (LC-MS/MS). Results: Evaluation of 1H-MRS data showed a decrease in 2-HG/total creatinine (tCr) ratios from the baseline to post-treatment scans in the mIDH1 murine model. Whole brain concentration of BAY1436032, as determined by 19F-MRS, was similar to total brain tissue concentration determined by Liquid Chromatography with tandem mass spectrometry (LC-MS/MS), with a signal loss due to protein binding. Intratumoral drug concentration, as determined by LC-MS/MS, was not statistically different in models with or without R132X-mutant IDH1 expression. Conclusions: Non-invasive monitoring of mIDH1 inhibition by BAY1436032 in mIDH1 gliomas is feasible.
2D NOESY plays a central role in structural NMR spectroscopy. We have recently discussed methods that rely on solvent-driven exchanges to enhance NOE correlations between exchangeable and non-exchangeable protons in nucleic acids. Such methods, however, fail when trying to establish connectivities within pools of labile protons. This study introduces an alternative that also enhances NOEs between such labile sites, based on encoding a priori selected peaks by selective saturations. The resulting selective magnetization transfer (SMT) experiment proves particularly useful for enhancing the imino–imino cross-peaks in RNAs, which is a first step in the NMR resolution of these structures. The origins of these enhancements are discussed, and their potential is demonstrated on RNA fragments derived from the genome of SARS-CoV-2, recorded with better sensitivity and an order of magnitude faster than conventional 2D counterparts.
Long non-coding RNAs are a very versatile class of molecules that can have important roles in regulating a cells function, including regulating other genes on the transcriptional level. One of these mechanisms is that RNA can directly interact with DNA thereby recruiting additional components such as proteins to these sites via a RNA:dsDNA triplex formation. We genetically deleted the triplex forming sequence (FendrrBox) from the lncRNA Fendrr in mice and find that this FendrrBox is partially required for Fendrr function in vivo. We find that the loss of the triplex forming site in developing lungs causes a dysregulation of gene programs, associated with lung fibrosis. A set of these genes contain a triplex site directly at their promoter and are expressed in fibroblasts. We confirm the formation of RNA:dsDNA formation with target promoters. We find that Fendrr with the Wnt signalling pathway regulates these genes, implicating that Fendrr synergizes with Wnt signalling in lung fibrosis.